IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS FOR USE IN METHODS OF TREATING TTP

    公开(公告)号:EP3332800A1

    公开(公告)日:2018-06-13

    申请号:EP18153676.4

    申请日:2015-06-16

    申请人: Ablynx NV

    发明人: Duby, Christian

    IPC分类号: A61K38/36 A61P7/00

    摘要: The present invention is based on the finding that administration of polypeptides comprising at least one Immunoglobulin single variable domains against vWF to human TTP patients provides a significant decrease in the time to response. The invention provides a polypeptide comprising at least one immunoglobulin single variable domain (ISVD) against von Willebrand Factor (vWF) for use in treating a vWF-related disease in a human in need thereof. The invention further relates to dosage unit forms, kits and medical uses for treating TTP.

    STABLE FORMULATIONS OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS AND USES THEREOF

    公开(公告)号:EP3511018A1

    公开(公告)日:2019-07-17

    申请号:EP19157147.0

    申请日:2014-05-16

    申请人: Ablynx NV

    IPC分类号: A61K39/395 A61K9/08

    摘要: The present invention relates to stable formulations of polypeptides, e.g. immunoglobulin single variable domains, in particular immunoglobulin single variable domains directed against von Willebrand Factor (vWF).
    The invention provides formulations which are stable upon storage for prolonged periods of time and over a broad range of temperatures. The formulations of the invention ensure a high stability of the polypeptide, allowing multiple freeze-thaw cycles without chemical or physical deterioration, and provide stability in relation to mechanical stress, such as shake, shear or stir stress. They are suitable for pharmaceutical and diagnostic preparations and compatible with pharmaceutically acceptable diluents.